Vyzkoušejte nový nástroj s podporou AI
Summon Research Assistant
BETA
Linagliptin and its effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: the randomized MARLINA‐T2D trial
Groop, Per‐Henrik, Cooper, Mark E., Perkovic, Vlado, Hocher, Berthold, Kanasaki, Keizo, Haneda, Masakazu, Schernthaner, Guntram, Sharma, Kumar, Stanton, Robert C., Toto, Robert, Cescutti, Jessica, Gordat, Maud, Meinicke, Thomas, Koitka‐Weber, Audrey, Thiemann, Sandra, von Eynatten, Maximilian
Published in Diabetes, obesity & metabolism (01.11.2017)
Published in Diabetes, obesity & metabolism (01.11.2017)
Get full text
Journal Article
Consistent effects of empagliflozin on cardiovascular and kidney outcomes irrespective of diabetic kidney disease categories: Insights from the EMPA‐REG OUTCOME trial
Wanner, Christoph, Inzucchi, Silvio E., Zinman, Bernard, Koitka‐Weber, Audrey, Mattheus, Michaela, George, Jyothis T., Eynatten, Maximilian, Hauske, Sibylle J.
Published in Diabetes, obesity & metabolism (01.12.2020)
Published in Diabetes, obesity & metabolism (01.12.2020)
Get full text
Journal Article
Empagliflozin and kidney outcomes in Asian patients with type 2 diabetes and established cardiovascular disease: Results from the EMPA‐REG OUTCOME® trial
Kadowaki, Takashi, Nangaku, Masaomi, Hantel, Stefan, Okamura, Tomoo, Eynatten, Maximilian, Wanner, Christoph, Koitka‐Weber, Audrey
Published in Journal of diabetes investigation (01.05.2019)
Published in Journal of diabetes investigation (01.05.2019)
Get full text
Journal Article
Short‐Term Changes in Albuminuria and Risk of Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus: A Post Hoc Analysis of the EMPA‐REG OUTCOME Trial
Waijer, Simke W., Xie, Di, Inzucchi, Silvio E., Zinman, Bernard, Koitka‐Weber, Audrey, Mattheus, Michaela, von Eynatten, Maximillian, Inker, Lesley A., Wanner, Christoph, Heerspink, Hiddo J. L.
Published in Journal of the American Heart Association (15.09.2020)
Published in Journal of the American Heart Association (15.09.2020)
Get full text
Journal Article
Cardio/Kidney Composite End Points: A Post Hoc Analysis of the EMPA‐REG OUTCOME Trial
Ferreira, João Pedro, Kraus, Bettina Johanna, Zwiener, Isabella, Lauer, Sabine, Zinman, Bernard, Fitchett, David H., Koitka‐Weber, Audrey, George, Jyothis T., Ofstad, Anne Pernille, Wanner, Christoph, Zannad, Faiez
Published in Journal of the American Heart Association (06.04.2021)
Published in Journal of the American Heart Association (06.04.2021)
Get full text
Journal Article
Disparate Effects of Diabetes and Hyperlipidemia on Experimental Kidney Disease
Watson, Anna M. D., Gould, Eleanor A. M., Moody, Sarah C., Sivakumaran, Priyadharshini, Sourris, Karly C., Chow, Bryna S. M., Koïtka-Weber, Audrey, Allen, Terri J., Jandeleit-Dahm, Karin A. M., Cooper, Mark E., Calkin, Anna C.
Published in Frontiers in physiology (03.06.2020)
Published in Frontiers in physiology (03.06.2020)
Get full text
Journal Article
Nephrotic-range proteinuria in type 2 diabetes: Effects of empagliflozin on kidney disease progression and clinical outcomes
Ruggenenti, Piero, Kraus, Bettina J., Inzucchi, Silvio E., Zinman, Bernard, Hantel, Stefan, Mattheus, Michaela, von Eynatten, Maximilian, Remuzzi, Giuseppe, Koitka-Weber, Audrey, Wanner, Christoph
Published in EClinicalMedicine (01.01.2022)
Published in EClinicalMedicine (01.01.2022)
Get full text
Journal Article
Characterization and implications of the initial estimated glomerular filtration rate ‘dip’ upon sodium-glucose cotransporter-2 inhibition with empagliflozin in the EMPA-REG OUTCOME trial
Kraus, Bettina J., Weir, Matthew R., Bakris, George L., Mattheus, Michaela, Cherney, David Z.I., Sattar, Naveed, Heerspink, Hiddo J.L., Ritter, Ivana, von Eynatten, Maximilian, Zinman, Bernard, Inzucchi, Silvio E., Wanner, Christoph, Koitka-Weber, Audrey
Published in Kidney international (01.03.2021)
Published in Kidney international (01.03.2021)
Get full text
Journal Article
Empagliflozin and Cardiovascular and Kidney Outcomes across KDIGO Risk Categories: Post Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled, Multinational Trial
Levin, Adeera, Perkovic, Vlado, Wheeler, David C., Hantel, Stefan, George, Jyothis T., von Eynatten, Maximilian, Koitka-Weber, Audrey, Wanner, Christoph
Published in Clinical journal of the American Society of Nephrology (07.10.2020)
Published in Clinical journal of the American Society of Nephrology (07.10.2020)
Get full text
Journal Article
Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial
Cherney, David Z I, Zinman, Bernard, Inzucchi, Silvio E, Koitka-Weber, Audrey, Mattheus, Michaela, von Eynatten, Maximilian, Wanner, Christoph
Published in The lancet. Diabetes & endocrinology (01.08.2017)
Published in The lancet. Diabetes & endocrinology (01.08.2017)
Get full text
Journal Article
Analysis from the EMPA-REG OUTCOME® trial indicates empagliflozin may assist in preventing the progression of chronic kidney disease in patients with type 2 diabetes irrespective of medications that alter intrarenal hemodynamics
Mayer, Gert J., Wanner, Christoph, Weir, Matthew R., Inzucchi, Silvio E., Koitka-Weber, Audrey, Hantel, Stefan, von Eynatten, Maximilian, Zinman, Bernard, Cherney, David Z.I.
Published in Kidney international (01.08.2019)
Published in Kidney international (01.08.2019)
Get full text
Journal Article
Cost-Effectiveness of Empagliflozin in Patients With Diabetic Kidney Disease in the United States: Findings Based on the EMPA-REG OUTCOME Trial
Reifsnider, Odette S., Kansal, Anuraag R., Wanner, Christoph, Pfarr, Egon, Koitka-Weber, Audrey, Brand, Sarah B., Stargardter, Matthew, Wang, Cheng, Kuti, Effie, Ustyugova, Anastasia
Published in American journal of kidney diseases (01.06.2022)
Published in American journal of kidney diseases (01.06.2022)
Get full text
Journal Article
Glucose Control and the Effect of Empagliflozin on Kidney Outcomes in Type 2 Diabetes: An Analysis From the EMPA-REG OUTCOME Trial
Cooper, Mark E., Inzucchi, Silvio E., Zinman, Bernard, Hantel, Stefan, von Eynatten, Maximilian, Wanner, Christoph, Koitka-Weber, Audrey
Published in American journal of kidney diseases (01.11.2019)
Published in American journal of kidney diseases (01.11.2019)
Get full text
Journal Article
Choice of endpoint in kidney outcome trials: considerations from the EMPA-REG OUTCOME® trial
Perkovic, Vlado, Koitka-Weber, Audrey, Cooper, Mark E, Schernthaner, Guntram, Pfarr, Egon, Woerle, Hans J, von Eynatten, Maximilian, Wanner, Christoph
Published in Nephrology, dialysis, transplantation (04.12.2020)
Published in Nephrology, dialysis, transplantation (04.12.2020)
Get full text
Journal Article
Neurovascular Response to Pressure in Patients With Diabetic Foot Ulcer
Vouillarmet, Julien, Josset-Lamaugarny, Audrey, Michon, Paul, Saumet, Jean Louis, Koitka-Weber, Audrey, Henni, Samir, Fromy, Berengere, Sigaudo-Roussel, Dominique
Published in Diabetes (New York, N.Y.) (01.04.2019)
Published in Diabetes (New York, N.Y.) (01.04.2019)
Get full text
Journal Article
Empagliflozin Improves Kidney Outcomes in Patients With or Without Heart Failure: Insights From the EMPA-REG OUTCOME Trial
Butler, Javed, Zannad, Faiez, Fitchett, David, Zinman, Bernard, Koitka-Weber, Audrey, von Eynatten, Maximilian, Zwiener, Isabella, George, Jyothis, Brueckmann, Martina, Cheung, Alfred K., Wanner, Christoph
Published in Circulation. Heart failure (01.06.2019)
Published in Circulation. Heart failure (01.06.2019)
Get full text
Journal Article
International consensus definitions of clinical trial outcomes for kidney failure: 2020
Levin, Adeera, Agarwal, Rajiv, Herrington, William G., Heerspink, Hiddo L., Mann, Johannes F.E., Shahinfar, Shahnaz, Tuttle, Katherine R., Donner, Jo-Ann, Jha, Vivekanand, Nangaku, Masaomi, de Zeeuw, Dick, Jardine, Meg J., Mahaffey, Kenneth W., Thompson, Aliza M., Beaucage, Mary, Chong, Kate, Roberts, Glenda V., Sunwold, Duane, Vorster, Hans, Warren, Madeleine, Damster, Sandrine, Malik, Charu, Perkovic, Vlado, Anand, Shuchi, Argent, Nicholas, Babak, Elena, Banerjee, Debasish, Barratt, Jonathan, Bello, Aminu K., Bernardo, Angelito A., Blais, Jaime, Canovatchel, William, Caskey, Fergus J., Coresh, Josef, de Boer, Ian H., Eckardt, Kai-Uwe, Evans, Rhys DR, Feldman, Harold I., Fogo, Agnes B., Gudmundsdottir, Hrefna, Hamano, Takayuki, Harris, David C.H., Hauske, Sibylle J., Haynes, Richard, Herzog, Charles A., Hiemstra, Thomas, Idorn, Thomas, Inker, Lesley, Ishida, Julie H., Johnson, David W., Jones-Burton, Charlotte, Joseph, Amer, Koitka-Weber, Audrey, Kretzler, Matthias, Lawatscheck, Robert, Liew, Adrian, Moist, Louise, Naicker, Saraladevi, Nakashima, Reiko, Patel, Uptal, Filho, Roberto Pecoits, Rose, Jennifer B., Rosenberg, Noah L., Sinsakul, Marvin, Smoyer, William E., Sola, Laura, Sood, Amy R., Stengel, Benedicte, Taal, Maarten W., Tanaka, Mototsugu, Tonelli, Marcello, Tong, Allison, Toto, Robert, Trask, Michele, Ulasi, Ifeoma I., Wanner, Christoph, Wheeler, David C., Wolthers, Benjamin O., Wright, Harold M., Yamada, Yoshihisa, Zakharova, Elena
Published in Kidney international (01.10.2020)
Published in Kidney international (01.10.2020)
Get full text
Journal Article
Empagliflozin and Kidney Function Decline in Patients with Type 2 Diabetes: A Slope Analysis from the EMPA-REG OUTCOME Trial
Wanner, Christoph, Heerspink, Hiddo J.L., Zinman, Bernard, Inzucchi, Silvio E., Koitka-Weber, Audrey, Mattheus, Michaela, Hantel, Stefan, Woerle, Hans-Juergen, Broedl, Uli C., von Eynatten, Maximilian, Groop, Per-Henrik
Published in Journal of the American Society of Nephrology (01.11.2018)
Published in Journal of the American Society of Nephrology (01.11.2018)
Get full text
Journal Article
Renal hemodynamic effects of sodium-glucose cotransporter 2 inhibitors in hyperfiltering people with type 1 diabetes and people with type 2 diabetes and normal kidney function
van Bommel, Erik J.M., Lytvyn, Yuliya, Perkins, Bruce A., Soleymanlou, Nima, Fagan, Nora M., Koitka-Weber, Audrey, Joles, Jaap A., Cherney, David Z.I., van Raalte, Daniël H.
Published in Kidney international (01.04.2020)
Published in Kidney international (01.04.2020)
Get full text
Journal Article
Kidney Function After Initiation and Discontinuation of Empagliflozin in Patients With Heart Failure With and Without Type 2 Diabetes: Insights From the EMPERIAL Trials
Anker, Stefan D., Ponikowski, Piotr, Wanner, Christoph, Pfarr, Egon, Hauske, Sibylle, Peil, Barbara, Salsali, Afshin, Ritter, Ivana, Koitka-Weber, Audrey, Brueckmann, Martina, Lindenfeld, JoAnn, Abraham, William T.
Published in Circulation (New York, N.Y.) (12.10.2021)
Published in Circulation (New York, N.Y.) (12.10.2021)
Get full text
Journal Article